Key points are not available for this paper at this time.
“If LDL-C lowering was the first revolution in preventive cardiology, the incorporation of ApoB and Lp(a) marks the beginning of the second, one rooted in particle biology, genetic risk, and refined precision prevention.”
A 2026 study studied this question.